A Descriptive Study to Explore Certain Characteristics of Patients at Risk for Chronic Obstructive Pulmonary Disease (COPD) in a Primary Care Setting

AstraZeneca

Status: Completed

Conditions: Chronic Obstructive Pulmonary Disease

Study type: Observational

Funder types: Industry

Identifiers

NCT01013922

NIS-RSE-DUM-2008/1

Details and patient eligibility

About

The purpose of this study is to explore if certain characteristics, easily detected within a regular primary care setting, may indicate that a patient at risk for COPD (45 ≤ age ≤ 80 years and a smoking history of ≥ 15 pack years) is prone to have a diagnosis of COPD according to Medical Products Agency guidelines.

Enrollment: 309 patients

Sex: All

Ages: 45 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with a history of smoking one pack of cigarettes per day for 15 years or more

Exclusion criteria

• Known Chronic Obstructive Pulmonary Disease
• Known severe cardiovascular disease

Trial design

309 participants in 1 patient group

No treatment

Description:

Patients with a smoking history of 15 pack years or more.